Skip to main content
Premium Trial:

Request an Annual Quote

Lion Licenses SRS to Lilly

NEW YORK, Jan. 17-Lion Bioscience has licensed its SRS data integration system to Eli Lilly and Company, the two companies said today.


Financial details were not available.


According to Lion, its SRS platform is used in more than 200 commercial and academic labs worldwide.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.